162 related articles for article (PubMed ID: 34465801)
21. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
[TBL] [Abstract][Full Text] [Related]
22. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2.
Sun M; Gomes S; Chen P; Frankenberger CA; Sankarasharma D; Chung CH; Chada KK; Rosner MR
Oncogene; 2014 Jul; 33(27):3528-37. PubMed ID: 23975428
[TBL] [Abstract][Full Text] [Related]
23. Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis.
Huang Q; Wei J; Wei L; Zhang X; Bai F; Wen S; Wei Y; Tan S; Lu Z; Lin X
J Cell Biochem; 2019 Apr; 120(4):6168-6177. PubMed ID: 30304566
[TBL] [Abstract][Full Text] [Related]
24. LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway.
Zong W; Feng W; Jiang Y; Cao Y; Ke Y; Shi X; Ju S; Cong H; Wang X; Cui M; Jing R
Gastric Cancer; 2020 Mar; 23(2):228-240. PubMed ID: 31451992
[TBL] [Abstract][Full Text] [Related]
25. RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN.
Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
Tumour Biol; 2014 Dec; 35(12):11949-58. PubMed ID: 25172097
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
27. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
[TBL] [Abstract][Full Text] [Related]
28. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
Ren G; Baritaki S; Marathe H; Feng J; Park S; Beach S; Bazeley PS; Beshir AB; Fenteany G; Mehra R; Daignault S; Al-Mulla F; Keller E; Bonavida B; de la Serna I; Yeung KC
Cancer Res; 2012 Jun; 72(12):3091-104. PubMed ID: 22505648
[TBL] [Abstract][Full Text] [Related]
29. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7.
Dangi-Garimella S; Yun J; Eves EM; Newman M; Erkeland SJ; Hammond SM; Minn AJ; Rosner MR
EMBO J; 2009 Feb; 28(4):347-58. PubMed ID: 19153603
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98.
Chen Z; Cheng Q; Ma Z; Xi H; Peng R; Jiang B
Biomed Res Int; 2013; 2013():695179. PubMed ID: 24392454
[TBL] [Abstract][Full Text] [Related]
31. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.
Lei X; Chang L; Ye W; Jiang C; Zhang Z
Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735
[TBL] [Abstract][Full Text] [Related]
32. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells.
Denoyelle C; Albanese P; Uzan G; Hong L; Vannier JP; Soria J; Soria C
Cell Signal; 2003 Mar; 15(3):327-38. PubMed ID: 12531431
[TBL] [Abstract][Full Text] [Related]
34. RKIP and 14-3-3ε exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently.
Yan L; Gu H; Li J; Xu M; Liu T; Shen Y; Chen B; Zhang G
Dig Dis Sci; 2013 Feb; 58(2):389-96. PubMed ID: 22899242
[TBL] [Abstract][Full Text] [Related]
35. Effect of Raf kinase inhibitor protein expression on malignant biological behavior and progression of colorectal cancer.
Wang Y; Wang LY; Feng F; Zhao Y; Huang MY; Shao Q; Chen C; Sheng H; Chen DL; Zeng ZL; Xu RH; Li YH
Oncol Rep; 2015 Oct; 34(4):2106-14. PubMed ID: 26238523
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.
Zhu CX; Li WZ; Guo YL; Chen L; Li GH; Yu JJ; Shu B; Peng S
Neoplasma; 2018; 65(2):228-233. PubMed ID: 29534584
[TBL] [Abstract][Full Text] [Related]
37. RKIP expression associated with gastric cancer cell invasion and metastasis.
Jia B; Liu H; Kong Q; Li B
Tumour Biol; 2012 Aug; 33(4):919-25. PubMed ID: 22246605
[TBL] [Abstract][Full Text] [Related]
38. Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion.
Ren S; Zhang N; Shen L; Lu Y; Chang Y; Lin Z; Sun N; Zhang Y; Xu J; Huang H; Jin H
Oncogene; 2021 Dec; 40(48):6579-6589. PubMed ID: 34615995
[TBL] [Abstract][Full Text] [Related]
39. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.
Dai H; Chen H; Liu W; You Y; Tan J; Yang A; Lai X; Bie P
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2107-17. PubMed ID: 27444299
[TBL] [Abstract][Full Text] [Related]
40. Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine.
Nie F; Cao J; Tong J; Zhu M; Gao Y; Ran Z
J Biomed Sci; 2015 Jul; 22(1):56. PubMed ID: 26177829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]